ReviewBreast (Edinburgh, Scotland)2024

Oral SERDs alone or in combination with CDK 4/6 inhibitors in breast cancer: Current perspectives and clinical trials.

Kleoniki Apostolidou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.